Silver Book Fact

Between 1984 and 1998, the cost of treating heart attack patients rose $10,000. However, medical technology increased the life expectancy of heart attack patients by an average of 1 year-a value of $70,000 and a net benefit of $60,000.

Cutler D, McClellan M. Is Technological Change in Medicine Worth It?. Health Affairs. 2001; 20(5): 11-29. http://content.healthaffairs.org/content/20/5/11.full

Reference

Title
Is Technological Change in Medicine Worth It?
Publication
Health Affairs
Publication Date
2001
Authors
Cutler D, McClellan M
Volume & Issue
Volume 20, Issue 5
Pages
11-29
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The rise in beta-blocker treatment rates (34% since 1996) is proof that sustained attention and effective initiatives saves lives and improves quality of life.  
  • In 1996, fewer than 2 in 3 patients were receiving beta-blocker drugs to prevent a second heart attack. In 2006, more than 97% of heart attack patients received these treatments,…  
  • It is estimated that the number of quality-adjusted life-years achieved with each $1 million spent on antihypertensive drug therapy is between 20-50 to more than 200.  
  • Between 1998 and 2008, the rate of death attributable to cardiovascular disease declined 30.6%.  
  • Cardiovascular disease death rates
    Cardiovascular disease accounts for nearly 801,000 deaths in the US, or about 1 of every 3 deaths in the US.